Endothelin-3 (Human)
ET-3 (Human, Porcine, Rat, Rabbit, Mouse)
4199-s 0.1 mg | 115.00 EUR
4199-v 0.5 mg | 325.00 EUR
Synthetic Product (disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
Cys – Thr – Cys – Phe – Thr – Tyr – Lys – Asp – Lys – Glu – Cys – Val – Tyr – Tyr – Cys – His – Leu – Asp – Ile – Ile – Trp
(M.W. 2643.0) | C121H168N26O33S4 | [117399-93-6] |
The purity is guaranteed to be higher than 99% by HPLC
The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.
References:
- M. Yanagisawa, A. Inoue, T. Ishikawa, Y. Kasuya, S. Kimura, S. Kumagaye, K. Nakajima, T.X. Watanabe, S. Sakakibara, K. Goto, and T. Masaki, Proc. Natl. Acad. Sci. USA, 85, 6964 (1988) (Original)
- A. Inoue, M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto, and T. Masaki, Proc. Natl. Acad. Sci. USA., 86, 2863 (1989) (Naming)
- K. Nakajima, S. Kumagaye, H. Nishio, H. Kuroda, T.X. Watanabe, Y. Kobayashi, H. Tamaoki, T. Kimura, and S. Sakakibara, J. Cardiovasc. Pharmacol., 13 Suppl.5, S8 (1989) (Chem. Synthesis & S-S Bond)
- K. Saida, N. Kometani, Y. Hirano, S. Oka, N. Tomizuka and Y. Mitsui, Peptide Chemistry 1996, 133 (1997) (cDNA Seq.; Mouse)
This peptide is distributed through Peptide Institute, Inc. under the license of Takeda Pharmaceutical Company, Ltd. and the National Institute of Advanced Industrial Scienence & Technology (AIST)